Cargando…

Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models

BACKGROUND: Sepsis is a major cause of mortality in Intensive Care Units. Anesthetic dose isoflurane and 100% oxygen were proved to be beneficial in sepsis; however, their application in septic patients is limited because long-term hyperoxia may induce oxygen toxicity and anesthetic dose isoflurane...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yi, Wang, Xiao-Xia, Sun, Dong-Dong, Zhang, Ze-Xin, Yang, Wan-Wan, Shao, Tian, Han, Han, Zhang, Er-Fei, Pu, Zhong-Shu, Hou, Zuo-Xu, Dong, Hai-Long, Xiong, Li-Ze, Hou, Li-Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381319/
https://www.ncbi.nlm.nih.gov/pubmed/28345549
http://dx.doi.org/10.4103/0366-6999.202734
_version_ 1782519916311609344
author Huang, Yi
Wang, Xiao-Xia
Sun, Dong-Dong
Zhang, Ze-Xin
Yang, Wan-Wan
Shao, Tian
Han, Han
Zhang, Er-Fei
Pu, Zhong-Shu
Hou, Zuo-Xu
Dong, Hai-Long
Xiong, Li-Ze
Hou, Li-Chao
author_facet Huang, Yi
Wang, Xiao-Xia
Sun, Dong-Dong
Zhang, Ze-Xin
Yang, Wan-Wan
Shao, Tian
Han, Han
Zhang, Er-Fei
Pu, Zhong-Shu
Hou, Zuo-Xu
Dong, Hai-Long
Xiong, Li-Ze
Hou, Li-Chao
author_sort Huang, Yi
collection PubMed
description BACKGROUND: Sepsis is a major cause of mortality in Intensive Care Units. Anesthetic dose isoflurane and 100% oxygen were proved to be beneficial in sepsis; however, their application in septic patients is limited because long-term hyperoxia may induce oxygen toxicity and anesthetic dose isoflurane has potential adverse consequences. This study was scheduled to find the optimal combination of isoflurane and oxygen in protecting experimental sepsis and its mechanisms. METHODS: The effects of combined therapy with isoflurane and oxygen on lung injury and sepsis were determined in animal models of sepsis induced by cecal ligation and puncture (CLP) or intraperitoneal injection of lipopolysaccharide (LPS) or zymosan. Mouse RAW264.7 cells or human peripheral blood mononuclear cells (PBMCs) were treated by LPS to probe mechanisms. The nuclear factor kappa B (NF-κB) signaling molecules were examined by Western blot and cellular immunohistochemistry. RESULTS: The 0.5 minimum alveolar concentration (MAC) isoflurane in 60% oxygen was the best combination of oxygen and isoflurane for reducing mortality in experimental sepsis induced by CLP, intraperitoneal injection of LPS, or zymosan. The 0.5 MAC isoflurane in 60% oxygen inhibited proinflammatory cytokines in peritoneal lavage fluids (tumor necrosis factor-alpha [TNF-α]: 149.3 vs. 229.7 pg/ml, interleukin [IL]-1β: 12.5 vs. 20.6 pg/ml, IL-6: 86.1 vs. 116.1 pg/ml, and high-mobility group protein 1 [HMGB1]: 323.7 vs. 449.3 ng/ml; all P < 0.05) and serum (TNF-α: 302.7 vs. 450.7 pg/ml, IL-1β: 51.7 vs. 96.7 pg/ml, IL-6: 390.4 vs. 722.5 pg/ml, and HMGB1: 592.2 vs. 985.4 ng/ml; all P < 0.05) in septic animals. In vitro experiments showed that the 0.5 MAC isoflurane in 60% oxygen reduced inflammatory responses in mouse RAW264.7 cells, after LPS stimulation (all P < 0.05). Suppressed activation of NF-κB pathway was also observed in mouse RAW264.7 macrophages and human PBMCs after LPS stimulation or plasma from septic patients. The 0.5 MAC isoflurane in 60% oxygen also prevented the increases of phospho-IKKβ/β, phospho-IκBβ, and phospho-p65 expressions in RAW264.7 macrophages after LPS stimulation (all P < 0.05). CONCLUSION: Combined administration of a sedative dose of isoflurane with 60% oxygen improves survival of septic animals through reducing inflammatory responses.
format Online
Article
Text
id pubmed-5381319
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-53813192017-04-26 Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models Huang, Yi Wang, Xiao-Xia Sun, Dong-Dong Zhang, Ze-Xin Yang, Wan-Wan Shao, Tian Han, Han Zhang, Er-Fei Pu, Zhong-Shu Hou, Zuo-Xu Dong, Hai-Long Xiong, Li-Ze Hou, Li-Chao Chin Med J (Engl) Original Article BACKGROUND: Sepsis is a major cause of mortality in Intensive Care Units. Anesthetic dose isoflurane and 100% oxygen were proved to be beneficial in sepsis; however, their application in septic patients is limited because long-term hyperoxia may induce oxygen toxicity and anesthetic dose isoflurane has potential adverse consequences. This study was scheduled to find the optimal combination of isoflurane and oxygen in protecting experimental sepsis and its mechanisms. METHODS: The effects of combined therapy with isoflurane and oxygen on lung injury and sepsis were determined in animal models of sepsis induced by cecal ligation and puncture (CLP) or intraperitoneal injection of lipopolysaccharide (LPS) or zymosan. Mouse RAW264.7 cells or human peripheral blood mononuclear cells (PBMCs) were treated by LPS to probe mechanisms. The nuclear factor kappa B (NF-κB) signaling molecules were examined by Western blot and cellular immunohistochemistry. RESULTS: The 0.5 minimum alveolar concentration (MAC) isoflurane in 60% oxygen was the best combination of oxygen and isoflurane for reducing mortality in experimental sepsis induced by CLP, intraperitoneal injection of LPS, or zymosan. The 0.5 MAC isoflurane in 60% oxygen inhibited proinflammatory cytokines in peritoneal lavage fluids (tumor necrosis factor-alpha [TNF-α]: 149.3 vs. 229.7 pg/ml, interleukin [IL]-1β: 12.5 vs. 20.6 pg/ml, IL-6: 86.1 vs. 116.1 pg/ml, and high-mobility group protein 1 [HMGB1]: 323.7 vs. 449.3 ng/ml; all P < 0.05) and serum (TNF-α: 302.7 vs. 450.7 pg/ml, IL-1β: 51.7 vs. 96.7 pg/ml, IL-6: 390.4 vs. 722.5 pg/ml, and HMGB1: 592.2 vs. 985.4 ng/ml; all P < 0.05) in septic animals. In vitro experiments showed that the 0.5 MAC isoflurane in 60% oxygen reduced inflammatory responses in mouse RAW264.7 cells, after LPS stimulation (all P < 0.05). Suppressed activation of NF-κB pathway was also observed in mouse RAW264.7 macrophages and human PBMCs after LPS stimulation or plasma from septic patients. The 0.5 MAC isoflurane in 60% oxygen also prevented the increases of phospho-IKKβ/β, phospho-IκBβ, and phospho-p65 expressions in RAW264.7 macrophages after LPS stimulation (all P < 0.05). CONCLUSION: Combined administration of a sedative dose of isoflurane with 60% oxygen improves survival of septic animals through reducing inflammatory responses. Medknow Publications & Media Pvt Ltd 2017-04-05 /pmc/articles/PMC5381319/ /pubmed/28345549 http://dx.doi.org/10.4103/0366-6999.202734 Text en Copyright: © 2017 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Huang, Yi
Wang, Xiao-Xia
Sun, Dong-Dong
Zhang, Ze-Xin
Yang, Wan-Wan
Shao, Tian
Han, Han
Zhang, Er-Fei
Pu, Zhong-Shu
Hou, Zuo-Xu
Dong, Hai-Long
Xiong, Li-Ze
Hou, Li-Chao
Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models
title Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models
title_full Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models
title_fullStr Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models
title_full_unstemmed Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models
title_short Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models
title_sort sub-anesthesia dose of isoflurane in 60% oxygen reduces inflammatory responses in experimental sepsis models
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381319/
https://www.ncbi.nlm.nih.gov/pubmed/28345549
http://dx.doi.org/10.4103/0366-6999.202734
work_keys_str_mv AT huangyi subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels
AT wangxiaoxia subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels
AT sundongdong subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels
AT zhangzexin subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels
AT yangwanwan subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels
AT shaotian subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels
AT hanhan subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels
AT zhangerfei subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels
AT puzhongshu subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels
AT houzuoxu subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels
AT donghailong subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels
AT xionglize subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels
AT houlichao subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels